Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Title:Subject Index To Volume 1
Volume: 2Issue: 1
Author(s):Science Publishers Bentham and Bentham Science Publishers
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Publishers Science and Bentham Science Publishers , Subject Index To Volume 1, Current Drug Targets - Immune, Endocrine & Metabolic Disorders 2002; 2 (1) .https://dx.doi.org/10.2174/1568008024606275
| DOI https://dx.doi.org/10.2174/1568008024606275 | Print ISSN 1568-0088 |
| Publisher Name Bentham Science Publisher | Online ISSN 1875-5917 |
Related Journals
Current Medicinal Chemistry
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
Related Books
Herbal Medicine for Autoimmune Diseases
The NLRP3 Inflammasome: An Attentive Arbiter of Inflammatory Response
Natural Immunomodulators: Promising Therapy for Disease Management
Herbal Immunity Boosters Against COVID-19
Mitochondrial DNA and the Immuno-inflammatory Response: New Frontiers to Control Specific Microbial Diseases
Frontiers in Clinical Drug Research - Anti Allergy Agents
Frontiers in Inflammation
8Related Articles
- Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug TargetsIn Silico Design of New B-Raf Kinase Type-II Inhibitors Through Combined Molecular Modeling Studies
Letters in Drug Design & DiscoveryMachine Learning Techniques and Drug Design
Current Medicinal ChemistryTumor Invasion and Oxidative Stress: Biomarkers and Therapeutic Strategies
Current Molecular Medicine Molecular Elements of Apoptosis-Regulating Pathways in Follicular Thyroid Cells: Mining for Novel Therapeutic Targets in the Treatment of Thyroid Carcinoma
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Leukocyte Function-Associated Antigen-1: Structure, Function and Application Prospects
Protein & Peptide LettersNovel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer
Clinical Cancer DrugsThe Role of Transcription Factors in the Formation of an Arrhythmogenic Substrate in Congestive Human Heart Failure
Current Medicinal ChemistryLRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers
Current Cancer Drug TargetsCYP24A1 as a Potential Target for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Statins And Stroke
Current Medicinal ChemistryRepurposing of Anticancer Drugs for the Treatment of Bacterial Infections
Current Topics in Medicinal ChemistrySynthesis of Sulfonamides, Metal Complexes and the Study of In vitro Biological Activities
Current Bioactive CompoundsN6-Isopentenyladenosine and its Analogue N6-Benzyladenosine Induce Cell Cycle Arrest and Apoptosis in Bladder Carcinoma T24 Cells
Anti-Cancer Agents in Medicinal Chemistry Rab5 in the Regulation of Cell Motility and Invasion
Current Protein & Peptide Science Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer
Mini-Reviews in Medicinal ChemistryGanoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs
Recent Patents on Anti-Cancer Drug DiscoveryFangchinoline Inhibited Proliferation of Neoplastic B-lymphoid Cells andAlleviated Sjögren’s Syndrome-like Responses in NOD/Ltj Mice via theAkt/mTOR Pathway
Current Molecular Pharmacology Ghrelin and Energy Balance: Focus on Current Controversies
Current Drug TargetsThe Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry
[8]ページ先頭